• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

sfox@unimelb.edu.au

Credentials


Position
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0002-7648-8896

Prof Stephen Fox

Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology

426 Scholarly works
40 Projects

HIGHLIGHTS

  • 2024

    Journal article

    BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
    DOI: 10.1186/s12943-024-02048-1
  • 2023

    Research grants (ARC, NHMRC, MRFF)

    Trial Integration of Polygenic Scores for Common Cancers Into Standard Clinical Care
  • 2022

    Journal article

    Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in mice.
    DOI: 10.1038/s43018-022-00413-x
  • 2022

    Research contracts (non-grants)

    Cancer State-Wide Project (iPREDICT2 Study)
  • 2020

    Research grants (ARC, NHMRC, MRFF)

    Super-Next: Complete Genome Profiling for Cancer of Unknown Primary
  • 2014

    Journal article

    Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts
    DOI: 10.1016/j.molonc.2014.01.008
  • 2013

    Journal article

    Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary
    DOI: 10.1002/path.4251
Stephen Fox

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Breast cancers arising in high mammographic density tissue harbor tumor-promoting immune profiles
    DOI: 10.1038/s41523-025-00884-y
  • 2026

    Journal article

    World Health Organization classification of tumours of the breast 6th edition 2026.
    DOI: 10.1111/his.70149
  • 2026

    Journal article

    Transcriptomic deconvolution reveals prognostic immune signatures and immunotherapy-responsive subtypes in male breast cancer.
    DOI: 10.1186/s13058-026-02236-5
  • 2026

    Journal article

    A worldwide survey on pathological measurement of residual breast cancer after neoadjuvant therapy: Different interpretations of the ypTNM classification
    DOI: 10.1016/j.ejca.2026.116354
  • 2026

    Journal article

    A Worldwide Survey on Pathological Measurement of Residual Breast Cancer After Neoadjuvant Therapy: Different Interpretations of the ypTNM Classification
    DOI: 10.1016/j.modpat.2026.100963
  • 2026

    Journal article

    Parity and lactation induce T-cell-mediated breast cancer protection
    DOI: 10.1038/s41586-025-09713-5
  • 2026

    Journal article

    Genomic Therapy Matching in Rare and Refractory Cancers
    DOI: 10.1001/jamaoncol.2026.0127
  • 2026

    Journal article

    Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory
    DOI: 10.1007/s40291-025-00820-7

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224